Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12020433 | 0.95 | CYP1A2 (0.33) | CYP1A2CYP2C19CYP3A4TSHRSRC | |
| SCHEMBL30611835 | 0.83 | APEX1 (0.39) | CYP2C19CYP3A4TSHRSRCL3MBTL1 | |
| SCHEMBL12533232 | 0.83 | APEX1 (0.39) | CYP2C19CYP3A4TSHRSRCL3MBTL1 | |
| SCHEMBL1552049 | 0.83 | APEX1 (0.39) | CYP2C19CYP3A4TSHRSRCL3MBTL1 | |
| SCHEMBL16301298 | 0.81 | CYP3A4 (0.41) | CYP1A2CYP2C19CYP3A4TSHRSRC | |
| SCHEMBL14823656 | 0.78 | CYP3A4 (0.37) | CYP3A4TSHRSRCL3MBTL1NPSR1 | |
| SCHEMBL5608915 | 0.78 | ALDH1A1 (0.34) | CYP1A2CYP2C19CYP3A4TSHRMAPK1 | |
| SCHEMBL12533235 | 0.77 | CYP3A4 (0.41) | CYP3A4TSHRL3MBTL1NPSR1MAPK1 | |
| SCHEMBL29800098 | 0.77 | TDP1 (0.43) | CYP3A4TSHRSRCL3MBTL1NPSR1 | |
| SCHEMBL317540 | 0.77 | TDP1 (0.43) | CYP3A4TSHRSRCL3MBTL1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968940-B2 | Redox shuttles for high voltage cathodes | UCHICAGO ARGONNE, LLC (US) | 2015-03-03 | — | — | US | disclosed |
| US-20110294018-A1 | REDOX SHUTTLES FOR HIGH VOLTAGE CATHODES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294018-A1 | REDOX SHUTTLES FOR HIGH VOLTAGE CATHODES | NOX4, SLC25A11, GPX4 | CYP1A2 921/4885CYP2C19 654/4885CYP3A4 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.